JP2008545725A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008545725A5 JP2008545725A5 JP2008513997A JP2008513997A JP2008545725A5 JP 2008545725 A5 JP2008545725 A5 JP 2008545725A5 JP 2008513997 A JP2008513997 A JP 2008513997A JP 2008513997 A JP2008513997 A JP 2008513997A JP 2008545725 A5 JP2008545725 A5 JP 2008545725A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- disease
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0511060.6A GB0511060D0 (en) | 2005-05-31 | 2005-05-31 | Organic compounds |
| GB0511060.6 | 2005-05-31 | ||
| PCT/EP2006/005106 WO2006128658A1 (en) | 2005-05-31 | 2006-05-29 | Ergoline derivatives and their use as chemokine receptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008545725A JP2008545725A (ja) | 2008-12-18 |
| JP2008545725A5 true JP2008545725A5 (enExample) | 2009-07-09 |
| JP5121703B2 JP5121703B2 (ja) | 2013-01-16 |
Family
ID=34834898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008513997A Expired - Fee Related JP5121703B2 (ja) | 2005-05-31 | 2006-05-29 | エルゴリン誘導体およびケモカイン受容体リガンドとしてのそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7666877B2 (enExample) |
| EP (1) | EP1893611A1 (enExample) |
| JP (1) | JP5121703B2 (enExample) |
| KR (1) | KR20080013971A (enExample) |
| CN (1) | CN101184754B (enExample) |
| AU (1) | AU2006254395B2 (enExample) |
| BR (1) | BRPI0611489A2 (enExample) |
| CA (1) | CA2608702C (enExample) |
| GB (1) | GB0511060D0 (enExample) |
| MX (1) | MX2007015084A (enExample) |
| RU (1) | RU2416613C2 (enExample) |
| WO (1) | WO2006128658A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG181896A1 (en) * | 2009-12-23 | 2012-07-30 | Map Pharmaceuticals Inc | Novel ergoline analogs |
| JP5874124B2 (ja) | 2010-06-28 | 2016-03-02 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 緑内障の処置に使用するための薬学的組成物 |
| CA2838991A1 (en) | 2011-06-23 | 2012-12-27 | Map Pharmaceuticals, Inc. | Novel fluoroergoline analogs |
| CA2859173A1 (en) | 2011-12-19 | 2013-06-27 | Map Pharmaceuticals, Inc. | Novel iso-ergoline derivatives |
| WO2013095708A1 (en) | 2011-12-21 | 2013-06-27 | Map Pharmaceuticals, Inc. | Novel neuromodulatory compounds |
| AU2012382929A1 (en) * | 2012-06-22 | 2015-02-05 | Map Pharmaceuticals, Inc. | Novel cabergoline derivatives |
| US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
| CN113149982A (zh) | 2015-01-20 | 2021-07-23 | Xoc制药股份有限公司 | 麦角灵化合物及其用途 |
| AU2016209490B2 (en) | 2015-01-20 | 2020-09-03 | Xoc Pharmaceuticals, Inc. | Isoergoline compounds and uses thereof |
| EP3630758A1 (en) | 2017-06-01 | 2020-04-08 | Xoc Pharmaceuticals, Inc | Ergoline derivatives for use in medicine |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| WO2020212951A1 (en) | 2019-04-17 | 2020-10-22 | Compass Pathfinder Limited | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
| WO2022232093A1 (en) | 2021-04-30 | 2022-11-03 | Mind Medicine, Inc. | Lsd salt crystal forms |
| AU2022331317B2 (en) | 2021-08-19 | 2025-09-11 | Definium Therapeutics US, Inc. | IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000042071A2 (en) * | 1999-01-12 | 2000-07-20 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
| RU2329263C2 (ru) | 2000-11-07 | 2008-07-20 | Новартис Аг | Производные имида индолилмалеиновой кислоты как ингибиторы протеинкиназы с |
| AR039209A1 (es) | 2002-04-03 | 2005-02-09 | Novartis Ag | Derivados de indolilmaleimida |
-
2005
- 2005-05-31 GB GBGB0511060.6A patent/GB0511060D0/en not_active Ceased
-
2006
- 2006-05-29 US US11/914,570 patent/US7666877B2/en not_active Expired - Fee Related
- 2006-05-29 JP JP2008513997A patent/JP5121703B2/ja not_active Expired - Fee Related
- 2006-05-29 CA CA2608702A patent/CA2608702C/en not_active Expired - Fee Related
- 2006-05-29 KR KR1020077027902A patent/KR20080013971A/ko not_active Withdrawn
- 2006-05-29 RU RU2007147597/04A patent/RU2416613C2/ru not_active IP Right Cessation
- 2006-05-29 EP EP06753946A patent/EP1893611A1/en not_active Withdrawn
- 2006-05-29 CN CN2006800186451A patent/CN101184754B/zh not_active Expired - Fee Related
- 2006-05-29 BR BRPI0611489-0A patent/BRPI0611489A2/pt not_active IP Right Cessation
- 2006-05-29 AU AU2006254395A patent/AU2006254395B2/en not_active Ceased
- 2006-05-29 MX MX2007015084A patent/MX2007015084A/es active IP Right Grant
- 2006-05-29 WO PCT/EP2006/005106 patent/WO2006128658A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008545725A5 (enExample) | ||
| JP2012504133A5 (enExample) | ||
| JP2011505356A5 (enExample) | ||
| JP2018518537A5 (enExample) | ||
| JP2008195730A5 (enExample) | ||
| JP2005508967A5 (enExample) | ||
| JP2011509259A5 (enExample) | ||
| JP2007145875A5 (enExample) | ||
| JP2013515472A5 (enExample) | ||
| JP2012041365A5 (enExample) | ||
| JP2008513498A5 (enExample) | ||
| HRP20140807T1 (hr) | Derivati pirolo[2,3-d]pirimidina kao inhibitori protein kinaze b | |
| JP2004534850A5 (enExample) | ||
| CA2409741A1 (en) | Tnf-.alpha. production inhibitors | |
| JP2009514837A5 (enExample) | ||
| JP2009510064A5 (enExample) | ||
| JP2009514836A5 (enExample) | ||
| JP2009514835A5 (enExample) | ||
| JP2020533352A5 (enExample) | ||
| JP2012513390A5 (enExample) | ||
| JP2007515476A5 (enExample) | ||
| JP2013506674A5 (enExample) | ||
| JP2008513510A5 (enExample) | ||
| JP2005526794A5 (ja) | ベンズイミダゾールおよびマイトジェン活性化およびｒｈｏキナーゼ阻害剤としてのその使用 | |
| RU2005138366A (ru) | Производные бензимидазола, композиции, содержащие их, их получение и их применение |